FDA AI Risk-Based Guidance Shifts Validation Burden to Sponsors

This matters as it enhances AI safety in clinical trials by enforcing sponsor accountability for validation.

Auto-scored: Governance guidance that mitigates AI misuse risks through regulatory enforcement.